Skip to main content
OpenTrials

Clinical trial condition

Poliomyelitis

Explore clinical trials studying Poliomyelitis. Study availability and eligibility vary by location and protocol.

172 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Poliomyelitis trial results

Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

NCT01287949

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD investigational site Clermont-Ferrand, France
  • Sanofi Pasteur MSD investigational site Lille, France
  • Sanofi Pasteur MSD investigational site Montpellier, France
  • Sanofi Pasteur MSD investigational site Paris, France
View Trial Details
Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

NCT01546909

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • SPMSD Investigational Site 120 Angers, France
  • SPMSD Investigational Site 103 Arras, France
  • SPMSD Investigational Site 155 Asnières, France
  • SPMSD Investigational Site 125 Bersée, France
View all 45 locations
View Trial Details
Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

NCT01249183

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD Investigational Site Angers, France
  • Sanofi Pasteur MSD Investigational Site Châtellerault, France
  • Sanofi Pasteur MSD Investigational Site Clermont-Ferrand, France
  • Sanofi Pasteur MSD Investigational Site Gières, France
View all 20 locations
View Trial Details
Completed

Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine

NCT02643446

Conditions
Blood-Borne Infections, Central Nervous System Diseases, Central Nervous System Infections, +22 more
Locations
  • Guangdong Center for Disease Control and Prevention Guangzhou, Guangdong, China
  • Hubei Center for Disease Control and Prevention Wuhan, Hubei, China
  • Jilin Center for Disease Control and Prevention Changchun, Jilin, China
  • Ningxia Center for Disease Control and Prevention Yinchuan, Ningxia, China
View Trial Details

Related conditions